Life Bio reaches first clinical milestone for OSK therapy
First patient dosed in Phase 1 trial testing epigenetic restoration approach for progressive age-related vision loss. The longevity…
Life Biosciences lands $80m to push cell reset therapy
Fresh funding backs the first human trial of a therapy designed to make older, damaged cells act younger…
FDA clears first human trial of epigenetic reprogramming therapy
A milestone moment for longevity as Life Biosciences gets green light to progress cellular rejuvenation trial in eye…